{"entity":{"type":"insider","cik":"0001500241","url":"/insider/0001500241","json_url":"/insider/0001500241.json","name":"Peacock Jonathan M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2015-02-23","last":"2025-04-29","span_basis":"filed_date"},"name_variants":[{"name":"Peacock Jonathan M","source":"filing","n_filings":10,"first_seen":"2015-02-23","last_seen":"2025-04-29"}],"transactions":[{"id":4439429,"accession":"0001722482-25-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001722482-25-000092","line_url":"/filing/0001722482-25-000092#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Avantor, Inc.","issuer_ticker":"AVTR","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8091.0,"shares_display":"8,091","price_per_share":12.81,"price_display":"12.81","price_state":"stated","total_value":103645.71,"total_display":"103,645.71","shares_owned_after":202715.0,"shares_owned_after_display":"202,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-28","filed_date":"2025-04-29","scope":"insider"},{"id":8560053,"accession":"0001600132-19-000085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600132-19-000085","line_url":"/filing/0001600132-19-000085#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.6099,"price_display":"0.61","price_state":"stated","total_value":12198.0,"total_display":"12,198.00","shares_owned_after":1875920.0,"shares_owned_after_display":"1,875,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-22","scope":"insider"},{"id":7826579,"accession":"0001600132-19-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600132-19-000043","line_url":"/filing/0001600132-19-000043#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":714286.0,"shares_display":"714,286","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":500000.2,"total_display":"500,000.20","shares_owned_after":1855920.0,"shares_owned_after_display":"1,855,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-25","filed_date":"2019-01-25","scope":"insider"},{"id":4909994,"accession":"0001600132-17-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600132-17-000111","line_url":"/filing/0001600132-17-000111#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":248962.0,"shares_display":"248,962","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":815351.0,"shares_owned_after_display":"815,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-29","filed_date":"2017-10-03","scope":"insider"},{"id":2691268,"accession":"0001628280-16-021725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-16-021725","line_url":"/filing/0001628280-16-021725#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":285715.0,"shares_display":"285,715","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":508417.0,"shares_owned_after_display":"508,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-11-30","scope":"insider"},{"id":3234894,"accession":"0001600132-16-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600132-16-000066","line_url":"/filing/0001600132-16-000066#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.3683,"price_display":"1.37","price_state":"stated","total_value":6841.5,"total_display":"6,841.50","shares_owned_after":222702.0,"shares_owned_after_display":"222,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-17","filed_date":"2016-05-18","scope":"insider"},{"id":8823515,"accession":"0001179110-15-016438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-016438","line_url":"/filing/0001179110-15-016438#line-2","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12800.0,"shares_display":"12,800","price_per_share":2.7606,"price_display":"2.76","price_state":"stated","total_value":35335.68,"total_display":"35,335.68","shares_owned_after":51727.0,"shares_owned_after_display":"51,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-16","filed_date":"2015-12-17","scope":"insider"},{"id":8823513,"accession":"0001179110-15-016438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-016438","line_url":"/filing/0001179110-15-016438#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":2.72,"price_display":"2.72","price_state":"stated","total_value":20400.0,"total_display":"20,400.00","shares_owned_after":38927.0,"shares_owned_after_display":"38,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider"},{"id":8235386,"accession":"0001179110-15-012431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-012431","line_url":"/filing/0001179110-15-012431#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.4754,"price_display":"5.48","price_state":"stated","total_value":27377.0,"total_display":"27,377.00","shares_owned_after":31427.0,"shares_owned_after_display":"31,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-19","filed_date":"2015-08-20","scope":"insider"},{"id":8684786,"accession":"0001179110-15-008413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-008413","line_url":"/filing/0001179110-15-008413#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5560.0,"shares_display":"5,560","price_per_share":8.6912,"price_display":"8.69","price_state":"stated","total_value":48323.072,"total_display":"48,323.07","shares_owned_after":26427.0,"shares_owned_after_display":"26,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-20","filed_date":"2015-05-22","scope":"insider"},{"id":8241241,"accession":"0001104659-15-013140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-013140","line_url":"/filing/0001104659-15-013140#line-1","is_derivative":false,"issuer_cik":"0001500241","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001500241","owner_cik":"0001500241","owner_name":"Peacock Jonathan M","owner_url":"/insider/0001500241","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20800.0,"shares_display":"20,800","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":249600.0,"total_display":"249,600.00","shares_owned_after":20867.0,"shares_owned_after_display":"20,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-19","filed_date":"2015-02-23","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722482","name":"Avantor, Inc.","url":"/issuer/0001722482","role":"Director","n_filings":1,"first_seen":"2025-04-29","last_seen":"2025-04-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001600132","name":"Bellerophon Therapeutics, Inc.","url":"/issuer/0001600132","role":"Director, Officer (President and CEO)","n_filings":9,"first_seen":"2015-02-23","last_seen":"2019-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001500241","retrieved_at":"2026-08-21T03:29:39+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}